Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.
about
Expression of miR-124 inhibits growth of medulloblastoma cellsCooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapyThe chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicityTargeted therapy for BRAFV600E malignant astrocytoma.How specific is the MRI appearance of supratentorial atypical teratoid rhabdoid tumors?A functional screening of the kinome identifies the Polo-like kinase 4 as a potential therapeutic target for malignant rhabdoid tumors, and possibly, other embryonal tumors of the brain.Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models.Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant gliomaAtypical teratoid rhabdoid tumors (ATRTs): the British Columbia's Children's Hospital's experience, 1986-2006.Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experieCombined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas.Ion channels in pediatric CNS Atypical Teratoid/Rhabdoid Tumor (AT/RT) cells: potential targets for novel therapeutic agents.Atypical Teratoid Rhabdoid Tumour : From Tumours to Therapies.
P2860
Q28279686-B1DD8CF2-82B1-431E-BA89-790D576A49EFQ36001219-9281EE02-FF54-4BD0-9BE9-23D7EDEF34BEQ36416243-03025DDA-525A-467C-8533-9263710ED856Q36800148-36AFD357-64FF-45FD-AB1F-0D771B19C9B9Q38059143-4BF17E25-0D80-4EB2-8BC0-E7EAFC57182AQ38708098-4E1EE73F-80DC-48BE-A199-E922D660AFF3Q38760366-E8EACC42-9742-4281-A997-A99F27167FA9Q39158242-F485CA5B-7F81-4991-ADB0-7530D70860F2Q41346638-93348A44-BEC4-4BAB-B3BA-CDAADEEA16A1Q43808068-3A3D3C1B-4DBD-4406-BF7E-0BC3426C536BQ45418245-0A05FF42-EFC4-407E-8879-D73263AC3D42Q46122173-270AA111-69D9-4FC6-BB14-9FEA1E4E69A2Q48860664-5E27738B-6DFD-4B26-A4CF-271677673679Q55102629-38F34944-4DA6-4CEB-8073-FB7463EF0AAD
P2860
Morphologic and molecular characterization of ATRT xenografts adapted for orthotopic therapeutic testing.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Morphologic and molecular char ...... rthotopic therapeutic testing.
@ast
Morphologic and molecular char ...... rthotopic therapeutic testing.
@en
Morphologic and molecular char ...... rthotopic therapeutic testing.
@nl
type
label
Morphologic and molecular char ...... rthotopic therapeutic testing.
@ast
Morphologic and molecular char ...... rthotopic therapeutic testing.
@en
Morphologic and molecular char ...... rthotopic therapeutic testing.
@nl
prefLabel
Morphologic and molecular char ...... rthotopic therapeutic testing.
@ast
Morphologic and molecular char ...... rthotopic therapeutic testing.
@en
Morphologic and molecular char ...... rthotopic therapeutic testing.
@nl
P2093
P2860
P356
P1433
P1476
Morphologic and molecular char ...... rthotopic therapeutic testing.
@en
P2093
Anu Banerjee
C David James
Jennifer Ayers-Ringler
Michael D Prados
Mitchel S Berger
Nalin Gupta
Rintaro Hashizume
Scott R VandenBerg
P2860
P304
P356
10.1093/NEUONC/NOP033
P577
2010-01-11T00:00:00Z